Nifty

:

23850.90

Sensex

:

78782.24

-453.45 (-1.87%)
-606.82 (-0.76%)

Login

Nifty
Sensex

:
:

23850.90
78782.24

-453.45 (-1.87%)
-606.82 (-0.76%)

Valiant Laboratories Ltd.

Pharmaceuticals & Drugs

Rating :

N/A

BSE: 543998 | NSE: VALIANTLAB

Watchlist

NSE BSE

138.98

05-Jul-2024

Open
High
Low
Previous Close

138.90
140.50
137.55
138.66

Volume
Traded Value (lacs)
52 Week High
52 Week Low

94468
131.29
214.95
100.20

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

493.81
N/A
10

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

463.65
N/A
2.09

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

-
-
-14.52

EBITDA CAGR (%)

10 Years
5 Years
3 Years

-
-
-

PAT CAGR (%)

10 Years
5 Years
3 Years

-
-
-76.88

P:E (Median)

8 Years
5 Years
3 Years

-
-
-

P:BV (Average)

8 Years
5 Years
3 Years

-
-
-

EV:EBITDA (Average)

8 Years
5 Years
3 Years

-
-
-

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Jun 24 Jun 23 Var% Mar 24 Mar 23 Var% Dec 23 Dec 22 Var% Sep 23 Sep 22 Var%
Net Sales 18.88 51.41 -63.28% 30.58 89.92 -65.99% 40.52 70.77 -42.74% 59.55 87.96 -32.30%
Expenses 21.27 47.59 -55.31% 35.11 81.30 -56.81% 46.82 60.85 -23.06% 60.93 77.27 -21.15%
EBITDA -2.39 3.81 - -4.53 8.61 - -6.31 9.93 - -1.39 10.68 -
EBIDTM -12.65% 7.42% -14.81% 9.58% -15.57% 14.03% -2.33% 12.15%
Other Income 2.17 2.44 -11.07% 2.50 1.72 45.35% 1.77 0.78 126.92% 2.96 1.47 101.36%
Interest 0.05 0.02 150.00% 0.02 0.03 -33.33% 0.02 0.04 -50.00% 0.02 0.17 -88.24%
Depreciation 0.50 0.46 8.70% 0.50 0.44 13.64% 0.49 0.40 22.50% 0.49 0.37 32.43%
PBT -0.77 5.78 - -2.55 9.87 - -5.04 10.27 - 1.06 11.61 -90.87%
Tax 0.23 1.51 -84.77% -1.33 2.04 - -1.54 2.62 - 0.27 2.96 -90.88%
PAT -1.01 4.27 - -1.22 7.83 - -3.50 7.65 - 0.79 8.66 -90.88%
PATM -5.32% 8.30% -3.98% 8.71% -8.65% 10.80% 1.33% 9.84%
EPS -0.23 0.98 - -0.28 1.80 - -0.81 1.76 - 0.18 2.00 -91.00%

Description Jun 24 Jun 23 Var% Mar 24 Mar 23 Var% Dec 23 Dec 22 Var% Sep 23 Sep 22 Var%
Net Sales 18.88 51.41 -63.28% 30.59 89.92 -65.98% 40.52 70.77 -42.74% 59.55 87.96 -32.30%
Expenses 21.27 47.59 -55.31% 35.12 81.30 -56.80% 46.82 60.85 -23.06% 60.93 77.27 -21.15%
EBITDA -2.39 3.81 - -4.53 8.61 - -6.31 9.93 - -1.39 10.68 -
EBIDTM -12.65% 7.42% -14.81% 9.58% -15.57% 14.03% -4.88% -4.88%
Other Income 2.81 2.44 15.16% 2.50 1.72 45.35% 1.77 0.78 126.92% 2.96 1.47 101.36%
Interest 0.05 0.02 150.00% 0.02 0.03 -33.33% 0.02 0.04 -50.00% 0.02 0.17 -88.24%
Depreciation 0.53 0.46 15.22% 0.52 0.44 18.18% 0.49 0.40 22.50% 0.49 0.37 32.43%
PBT -0.16 5.78 - -2.57 9.87 - -5.04 10.27 - 1.06 11.61 -90.87%
Tax 0.35 1.51 -76.82% -1.33 2.04 - -1.54 2.62 - 0.27 2.96 -90.88%
PAT -0.51 4.27 - -1.24 7.83 - -3.50 7.65 - 0.79 8.66 -90.88%
PATM -2.70% 8.30% -4.05% 8.71% -8.65% 10.80% -10.84% -10.84%
EPS -0.12 1.31 - -0.29 2.40 - -0.81 2.35 - -0.96 -0.96 -

Annual Results

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description TTM Mar 24 Mar 23 Mar 22
Net Sales 149.53 182.05 333.91 291.52 Net Sales Growth -50.17% -45.48% 14.54% Cost Of Goods Sold 144.95 167.52 276.52 234.22 Gross Profit 4.58 14.52 57.39 57.30 GP Margin 3.07% 7.98% 17.19% 19.66% Total Expenditure 164.13 190.46 298.84 249.21 Power & Fuel Cost - 8.33 7.37 4.38 % Of Sales - 4.58% 2.21% 1.50% Employee Cost - 4.31 4.61 3.06 % Of Sales - 2.37% 1.38% 1.05% Manufacturing Exp. - 6.15 5.13 3.93 % Of Sales - 3.38% 1.54% 1.35% General & Admin Exp. - 0.78 0.90 0.53 % Of Sales - 0.43% 0.27% 0.18% Selling & Distn. Exp. - 2.00 2.97 2.03 % Of Sales - 1.10% 0.89% 0.70% Miscellaneous Exp. - 1.37 1.34 1.06 % Of Sales - 0.75% 0.40% 0.36% EBITDA -14.62 -8.41 35.07 42.31 EBITDA Margin -9.78% -4.62% 10.50% 14.51% Other Income 9.40 9.68 4.89 1.95 Interest 0.11 0.08 0.25 0.07 Depreciation 1.98 1.95 1.56 2.49 PBT -7.30 -0.75 38.14 41.70 Tax -2.37 -1.09 9.14 14.21 Tax Rate 32.47% 145.33% 23.96% 34.08% PAT -4.94 0.34 29.00 27.50 PAT before Minority Interest -4.94 0.34 29.00 27.50 Minority Interest 0.00 0.00 0.00 0.00 PAT Margin -3.30% 0.19% 8.68% 9.43% PAT Growth -117.39% -98.83% 5.45% EPS -1.14 0.08 6.68 6.34

Description TTM Mar 24 Mar 23
Net Sales 149.54 182.06 333.91 Net Sales Growth -50.16% -45.48% Cost Of Goods Sold 1,091.63 167.53 276.52 Gross Profit -942.09 14.53 57.39 GP Margin -629.99% 7.98% 17.19% Total Expenditure 164.14 190.47 298.84 Power & Fuel Cost - 8.33 7.37 % Of Sales - 4.58% 2.21% Employee Cost - 4.31 4.61 % Of Sales - 2.37% 1.38% Manufacturing Exp. - 6.15 5.13 % Of Sales - 3.38% 1.54% General & Admin Exp. - 0.78 0.90 % Of Sales - 0.43% 0.27% Selling & Distn. Exp. - 2.00 2.97 % Of Sales - 1.10% 0.89% Miscellaneous Exp. - 1.37 1.34 % Of Sales - 0.75% 0.40% EBITDA -14.62 -8.41 35.07 EBITDA Margin -9.78% -4.62% 10.50% Other Income 10.04 9.68 4.89 Interest 0.11 0.08 0.25 Depreciation 2.03 1.97 1.56 PBT -6.71 -0.77 38.14 Tax -2.25 -1.09 9.14 Tax Rate 33.53% 141.56% 23.96% PAT -4.46 0.32 29.00 PAT before Minority Interest -4.73 0.32 29.00 Minority Interest -0.27 0.00 0.00 PAT Margin -2.98% 0.18% 8.68% PAT Growth -115.70% -98.90% EPS -1.03 0.07 6.68

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description Mar 24 Mar 23 Mar 22
Shareholder's Funds 236.88 100.49 71.46 Share Capital 43.45 32.56 16.28 Total Reserves 193.43 67.93 55.18 Non-Current Liabilities 61.48 61.75 60.92 Secured Loans 0.00 0.00 0.00 Unsecured Loans 59.40 59.40 59.40 Long Term Provisions 0.08 0.08 0.00 Current Liabilities 26.36 50.52 49.43 Trade Payables 24.76 47.30 46.44 Other Current Liabilities 1.48 3.10 1.55 Short Term Borrowings 0.00 0.00 1.28 Short Term Provisions 0.12 0.12 0.16 Total Liabilities 324.72 212.76 181.81 Net Block 31.61 29.97 22.23 Gross Block 42.35 38.76 29.75 Accumulated Depreciation 10.74 8.79 7.53 Non Current Assets 115.46 30.80 25.01 Capital Work in Progress 0.22 0.05 1.45 Non Current Investment 80.97 0.01 0.00 Long Term Loans & Adv. 2.66 0.77 1.34 Other Non Current Assets 0.00 0.00 0.00 Current Assets 209.27 181.96 156.80 Current Investments 37.61 34.02 0.40 Inventories 10.02 13.04 15.80 Sundry Debtors 45.72 88.57 110.77 Cash & Bank 96.72 0.46 20.13 Other Current Assets 19.20 1.24 0.88 Short Term Loans & Adv. 17.19 44.64 8.81 Net Current Assets 182.90 131.44 107.37 Total Assets 324.73 212.76 181.81

Description Mar 24 Mar 23
Shareholder's Funds 236.86 100.49 Share Capital 43.45 32.56 Total Reserves 193.41 67.93 Non-Current Liabilities 76.75 61.75 Secured Loans 15.26 0.00 Unsecured Loans 59.40 59.40 Long Term Provisions 0.08 0.08 Current Liabilities 29.08 50.73 Trade Payables 25.93 47.30 Other Current Liabilities 1.65 3.31 Short Term Borrowings 1.39 0.00 Short Term Provisions 0.12 0.12 Total Liabilities 342.69 212.97 Net Block 50.05 48.12 Gross Block 70.21 66.31 Accumulated Depreciation 20.15 18.19 Non Current Assets 117.14 62.39 Capital Work in Progress 42.65 0.68 Non Current Investment 0.00 0.00 Long Term Loans & Adv. 24.44 13.59 Other Non Current Assets 0.00 0.00 Current Assets 225.54 150.58 Current Investments 37.61 34.02 Inventories 10.02 13.04 Sundry Debtors 45.73 88.57 Cash & Bank 106.21 1.34 Other Current Assets 25.98 1.24 Short Term Loans & Adv. 23.96 12.37 Net Current Assets 196.47 99.85 Total Assets 342.68 212.97

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description Mar 24 Mar 23 Mar 22
Cash From Operating Activity 48.78 22.96 2.25 PBT -0.75 38.14 41.70 Adjustment 2.03 1.82 3.06 Changes in Working Capital 46.53 -8.20 -28.05 Cash after chg. in Working capital 47.80 31.76 16.72 Interest Paid 0.00 0.00 0.00 Tax Paid 0.98 -8.80 -14.47 Other Direct Exp. Paid 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 Cash From Investing Activity -182.73 -21.18 -12.24 Net Fixed Assets -3.76 -7.61 Net Investments -84.55 -33.63 Others -94.42 20.06 Cash from Financing Activity 135.80 -1.53 6.18 Net Cash Inflow / Outflow 1.85 0.24 -3.81 Opening Cash & Equivalents 0.38 0.13 3.94 Closing Cash & Equivalent 2.23 0.38 0.13

Description Mar 24 Mar 23
Cash From Operating Activity 1.89 56.05 PBT -0.77 38.14 Adjustment 2.04 1.56 Changes in Working Capital -0.37 25.16 Cash after chg. in Working capital 0.90 64.85 Interest Paid 0.00 0.00 Tax Paid 0.98 -8.80 Other Direct Exp. Paid 0.00 0.00 Extra & Other Items 0.00 0.00 Cash From Investing Activity -143.88 -55.17 Net Fixed Assets -3.76 Net Investments -84.55 Others -55.57 Cash from Financing Activity 152.45 -0.93 Net Cash Inflow / Outflow 10.46 -0.05 Opening Cash & Equivalents 1.26 1.31 Closing Cash & Equivalent 11.72 1.26

Financial Ratios

Standalone /

Consolidated

Right to Left

Description Mar 24 Mar 23 Mar 22
Book Value (Rs.) 54.52 30.86 21.95 ROA 0.13% 14.70% 15.12% ROE 0.20% 33.73% 38.48% ROCE -0.30% 26.29% 31.62% Fixed Asset Turnover 4.49 9.75 9.80 Receivable days 134.62 108.95 138.69 Inventory Days 23.11 15.77 19.79 Payable days 78.50 61.86 72.37 Cash Conversion Cycle 79.23 62.85 86.11 Total Debt/Equity 0.25 0.59 0.85 Interest Cover -8.67 151.32 572.29

Description Mar 24 Mar 23
Book Value (Rs.) 54.51 30.86 ROA 0.12% 13.62% ROE 0.19% 28.86% ROCE -0.29% 24.01% Fixed Asset Turnover 2.67 5.04 Receivable days 134.62 96.82 Inventory Days 23.11 14.26 Payable days 79.77 62.43 Cash Conversion Cycle 77.97 48.64 Total Debt/Equity 0.32 0.59 Interest Cover -8.89 151.32

Top Investors:

jainam broking limited

priyanka shwetkumar koradiya

Annual Reports:

News Update:

Valiant Laboratories - Quarterly Results
12th Aug 2024, 17:05 PM

Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback